SciSparc (SPRC) Other financing activities (2016 - 2025)
SciSparc (SPRC) posted Other financing activities of $810000.0 for Q2 2025, little changed sequentially from $810000.0 in Q4 2024, and little changed YoY from $810000.0 in Q2 2024.
SciSparc (SPRC) Other financing activities (2016 - 2025) Analysis & Trends
SciSparc has reported Other financing activities for 10 years, with the latest figure at $810000.0 in Q2 2025.
- Quarterly Other financing activities changed 0.0% year-over-year to $810000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $810000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $810000.0, down 72.86% from the prior year.
- Other financing activities held at $810000.0 in Q2 2025 per SPRC's latest filing, from $810000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $5.2 million in Q3 2022 and troughed at $559000.0 in Q2 2021.
- A 5-year average of $1.1 million and a median of $761000.0 in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2023: Other financing activities changed 0.0% in 2021, then jumped 44.9% in 2023.
- Over 5 years, Other financing activities stood at $559000.0 in 2021, then changed by 0.0% to $559000.0 in 2022, then surged by 44.9% to $810000.0 in 2023, then changed by 0.0% to $810000.0 in 2024, then changed by 0.0% to $810000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $810000.0, $810000.0, and $810000.0 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 810,000.00 |
| Jun 30, 2025 | 810,000.00 |
| Dec 31, 2024 | 810,000.00 |
| Dec 31, 2024 | 810,000.00 |
| Jun 30, 2024 | 810,000.00 |
| Jun 30, 2024 | 810,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Jun 30, 2023 | 712,000.00 |
| Jun 30, 2023 | 712,000.00 |
| Dec 31, 2022 | 559,000.00 |
| Dec 31, 2022 | 559,000.00 |
| Sep 30, 2022 | 5.19 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 559,000.00 |
| Jun 30, 2022 | 559,000.00 |
| Dec 31, 2021 | 559,000.00 |
| Dec 31, 2021 | 559,000.00 |
| Jun 30, 2021 | 559,000.00 |
| Jun 30, 2021 | 559,000.00 |